Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
542.71
488.48
477.22
446.45
282.08
243.44
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
542.71
488.48
477.22
446.45
282.08
243.44
Raw Material Cost
443.59
350.32
311.43
284.37
164.99
149.31
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
156.51
84.75
67.81
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
9.49
5.64
4.95
2.67
1.42
1.35
Selling and Distribution Expenses
71.11
67.00
73.63
56.72
43.03
36.45
Other Expenses
2.81
2.68
2.49
-14.29
-7.52
-5.97
Total Expenditure (Excl Depreciation)
552.27
449.71
414.87
357.41
219.02
195.18
Operating Profit (PBDIT) excl Other Income
-9.6
38.8
62.400000000000006
89
63.099999999999994
48.3
Other Income
16.32
8.70
17.58
1.53
-4.02
5.89
Operating Profit (PBDIT)
85.52
85.35
115.42
115.26
72.57
66.43
Interest
9.49
5.64
4.95
2.67
1.42
1.35
Exceptional Items
5.14
5.59
0.10
0.40
0.00
0.27
Gross Profit (PBDT)
99.12
138.16
165.79
162.08
117.09
94.13
Depreciation
77.64
48.53
37.65
26.76
15.93
13.33
Profit Before Tax
3.54
36.76
72.92
86.23
55.22
52.02
Tax
-13.55
-0.86
5.75
12.66
6.52
4.77
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.08
37.62
67.18
73.58
48.69
47.25
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.08
37.62
67.18
73.58
48.69
47.25
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17.08
37.62
67.18
73.58
48.69
47.25
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,032.70
1,117.54
1,112.88
348.44
263.18
200.07
Earnings per share (EPS)
0.12
0.27
0.48
0.53
0.35
0.34
Diluted Earnings per share
0.12
0.27
0.48
0.53
0.35
0.34
Operating Profit Margin (Excl OI)
-1.55%
5.76%
12.61%
19.48%
21.5%
19.39%
Gross Profit Margin
14.96%
17.46%
23.17%
25.31%
25.22%
26.85%
PAT Margin
3.15%
7.7%
14.08%
16.48%
17.26%
19.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 11.10% vs 2.37% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -54.52% vs -44.05% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is -9.66% vs -21.68% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 69.64% vs 14.29% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of PharmaResources (Shanghai) Co., Ltd With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
542.71
0
542.71
Other Operating Income
0.00
0.00
0.00
Total Operating income
542.71
0
542.71
Raw Material Cost
443.59
0
443.59
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
9.49
0
9.49
Selling and Distribution Expenses
71.11
0
71.11
Other Expenses
2.81
0.00
2.81
Total Expenditure (Excl Depreciation)
552.27
0
552.27
Operating Profit (PBDIT) excl Other Income
-9.57
0.00
-9.57
Other Income
16.32
0
16.32
Operating Profit (PBDIT)
85.52
0
85.52
Interest
9.49
0
9.49
Exceptional Items
5.14
0
5.14
Gross Profit (PBDT)
99.12
0
99.12
Depreciation
77.64
0
77.64
Profit Before Tax
3.54
0
3.54
Tax
-13.55
0
-13.55
Provisions and contingencies
0
0
0.00
Profit After Tax
17.08
0
17.08
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
17.08
0
17.08
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17.08
0
17.08
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,032.70
0
1,032.70
Earnings per share (EPS)
0.12
0
0.12
Diluted Earnings per share
0.12
0
0.12
Operating Profit Margin (Excl OI)
-1.55%
0%
0.00
-1.55%
Gross Profit Margin
14.96%
0%
0.00
14.96%
PAT Margin
3.15%
0%
0.00
3.15%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 54.27 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 11.10% vs 2.37% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 1.71 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -54.52% vs -44.05% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.92 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -9.66% vs -21.68% in Dec 2023
Annual - Interest
Interest 0.95 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 69.64% vs 14.29% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -1.55%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023






